REGISTERED
on 13 Feb 2024
Last Applicant/ Owned by
Place du Port 2
Neuchâtel
CH
2000
Serial Number
97523311 filed on 07th Jul 2022
Registration Number
7306495 registered on 13th Feb 2024
Correspondent Address
Maxim A. Voltchenko
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)
Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled
Classification Information
Class [005]
Pharmaceutical Products
Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled
First Use Date in General
18th Aug 2022
First Use Date in Commerce
18th Aug 2022
Specimens
Mark Details
Serial Number
No 97523311
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 4007-113TMUS
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
07.09.06 -
Triumphal arches, arches, porticos
19.05.25 -
Other large containers, including dumpsters and freight containers
26.03.14 -
Three or more ovals
26.03.16 -
Ovals touching or intersecting
26.03.21 -
Ovals that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Jan 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 08th Jan 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 05th Jan 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 05th Jan 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 14th Dec 2023 | TEAS STATEMENT OF USE RECEIVED |
| 14th Dec 2023 | USE AMENDMENT FILED |
| 17th Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 22nd Aug 2023 | PUBLISHED FOR OPPOSITION |